General and pediatric “Treat All” policies lead to increased ART initiation among 10- to 14-year-olds in sub-Saharan Africa

December 2019

For immediate release A new study published as “Editor’s Choice” in The Journal of Infectious Diseases found that expansion of HIV treatment eligibility to include those under age 15 led to large and significant increases in initiation of antiretroviral therapy (ART) within 30 days of enrollment in care among 10- to 14-year-olds living with HIV. […]


A Randomized Controlled Trial to Evaluate Adding Self-administered Oral HIV testing as a Choice in Clinic and Non-clinic Settings to Increase HIV Testing Uptake Among Truck Drivers in Kenya

This project is a randomized controlled trial to evaluate HIV test uptake among truck drivers recruited from two roadside wellness clinics in Kenya when offered a choice between the standard, clinic based, provider administered blood based rapid HIV test versus a choice between the standard HIV test or self-administered oral rapid HIV test that can […]


Multi-level determinants of Late ART Initiation in Sub-Saharan Africa (LSTART)

The LSTART Study examines the multi-level factors associated with late antiretroviral therapy (ART) initiation in Kenya, Mozambique, Rwanda, Ethiopia and Tanzania. The study covers multiple areas including, 1) multi-level factors (contextual, clinic, and individual) associated with late ART initiation; 2) clinic-level barriers and enablers to timely enrollment, identified through observation of provider-patient interactions and provider […]